Sept 25 (Reuters) - Mabion MABP.WA :
* SAID ON TUESDAY COMPANY HAS DECIDED TO START ACTIONS AIMED
AT
SECURING SUBSIDY DEAL WITH POLISH AGENCY FOR ENTERPRISE
DEVELOPMENT
* DEAL TO FUND PROJECT ON DEVELOPMENT OF INNOVATIVE
TECHNOLOGY FOR
OBTAINING STABLE CELL LINES PRODUCING BISPECIFIC ANTIBODIES AND
THERAPEUTIC PROTEINS
* TOTAL PROJECT COST ESTIMATED AT 13.1 MLN ZLOTYS
* GRANTED SUBSIDY AMOUNTS TO 6.4 MLN ZLOTYS
* PROJECT COMPLETION SET FOR DECEMBER 2028
Source text for Workspace: urn:newsml:reuters.com:*:nEMcdylMJa
Further company coverage: MABP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))